Читать книгу Protein in Neonatal and Infant Nutrition: Recent Updates - Группа авторов - Страница 41

pHF and eHF represent a valid substitute of CM-SFs in infants at risk for or with CMA. The degree and method of hydrolysis, and nonnitrogen and additional components determine the efficacy, tolerance and nutritional effect of different HF. pHF may offer a beneficial preventive effect on eczema in formula-fed newborns with a family risk of atopy. eHF is tolerated by 90% of infants with CMA and is the treatment of choice in all except severe cases of CMA. Promising results were recently obtained with eHRPF. Nutritional adequacy of the HF should be carefully evaluated to ensure appropriate growth in allergic infants. A proper diagnostic approach and follow-up are necessary to avoid unnecessary or excessively prolonged use of HF.